Clinical Trials Logo
  1. Home
  2. Lower Urinary Tract Symptoms
  3. NCT04648176
  4. Details
NCT04648176 Clinical Trial

Application of MOSES Technology in BPH

Lower Urinary Tract Symptoms Clinical Trial

Official title:
Evaluation of Surgical and Functional Results of the Application of MOSES Technology in the Holmium Laser Prostate Enucleation as a Treatment for Tract Symptoms Lower Urinary Secondary to Benign Prostatic Hyperplasia

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04648176
Other study ID # PR(AG)501/2019
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 6, 2020
Est. completion date June 30, 2023

Study information
Verified date November 2020
Source Hospital Universitari Vall d'Hebron Research Institute
Contact Adrià Piñero Zomeño, MD
Phone 934893000
Email adria.pinero@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study the investigators intend to compare the surgical and functional results of two different modalities of the use of the Holmium laser in prostate enucleation.

Description:

In this study the investigators intend to compare the surgical and functional results of two different modalities of the use of the Holmium laser in prostate enucleation using MOSES technology.

Recruitment information / eligibility
Status Recruiting
Enrollment 400
Est. completion date June 30, 2023
Est. primary completion date June 30, 2022
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Prostatic volume between 70-200cc - Acceptance to participate in the study. Exclusion Criteria: - Previous urethra stricture - Previous prostate surgery - Neurogenic bladder - Bladder tumor - Neurological disease with repercussion in the lower urinary tract. - Severe psychiatric illness - Inability of the patient to consent

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Moses technology
Using Holmium laser with Moses technology or conventional one

Locations
Country Name City State
Spain Vall d'Hebron University Hospital Barcelona

Sponsors (1)
Lead Sponsor Collaborator
Hospital Universitari Vall d'Hebron Research Institute

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary Hemoglobin Hemoglobin change 24 hours after the surgery
Secondary Enucleation time Enucleation time change during the surgery
Secondary Hemostasis time Hemostasis time change during the surgery
Secondary Morcellating time Morcellating time change during the surgery
Secondary Surgery time Surgery time change during the surgery
Secondary Irrigated volume of serum Irrigated volume of serum change during the surgery
Secondary complication rate difference of complication rate one month after the surgery
Secondary urinary tract infection urinary tract infection rate differences one month after the surgery
Secondary lower urinary tract symptoms lower urinary tract symptoms rate differences through study completion, an average of 3 years
Secondary sexual function sexual function differences through study completion, an average of 3 years
See also
  Status Clinical Trial Phase
Completed NCT04856748 - Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
Completed NCT03623880 - Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders N/A
Enrolling by invitation NCT06317116 - Examining the Relationship Between Core Muscles and Bladder Issues in Children
Completed NCT03625843 - Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing N/A
Recruiting NCT05814614 - Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation N/A
Recruiting NCT04288427 - 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy N/A
Not yet recruiting NCT06452927 - EEP in Patients With Urodynamically Proven DU/DA N/A
Completed NCT02330107 - Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men N/A
Completed NCT03339609 - Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children N/A
Terminated NCT02003742 - Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH Phase 3
Terminated NCT01003249 - Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen Phase 4
Completed NCT01078545 - Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) N/A
Completed NCT02074644 - Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia N/A
Recruiting NCT03802851 - HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer N/A
Active, not recruiting NCT05415748 - Deprescribing Tamsulosin in Older Men Phase 4
Recruiting NCT05702294 - Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries . N/A
Enrolling by invitation NCT05537272 - The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy Phase 4
Recruiting NCT05826691 - Benign Prostate Surgery and QOL and Sexual Function
Completed NCT04104100 - Prevalence and Risk Factor of NP in Women With LUTS
Completed NCT04190641 - Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder N/A